Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -293.85 Million | -281.82 Million | -159.53 Million | -172.99 Million | -111.76 Million | -99.18 Million |
| Net Income | -577.75 Million | -429.13 Million | -314.41 Million | -363.01 Million | -203.54 Million | 9.06 Million |
| Depreciation & Amortization | 13.24 Million | 12.46 Million | 11 Million | 10.98 Million | 9.05 Million | 7.08 Million |
| Deferred income taxes | -1.83 Million | -35.92 Million | -2.12 Million | -373 Thousand | -6.11 Million | -35.67 Million |
| Stock-based compensation | 74.84 Million | 90.18 Million | 31.41 Million | 12.64 Million | - | 4.95 Million |
| Change in working capital | 69.55 Million | -2.79 Million | 3.79 Million | 7.24 Million | 6 Million | -17.6 Million |
| Other non-cash items | 128.09 Million | 83.38 Million | 110.77 Million | 159.5 Million | 98.99 Million | -48.95 Million |
| Investing Cash Flow | -28.51 Million | 79.84 Million | -39.92 Million | -38.17 Million | -21.19 Million | -16.52 Million |
| Investments in PPE | -13.65 Million | -8.87 Million | -37.57 Million | -11.44 Million | -21.19 Million | -10.97 Million |
| Acquisitions | -14.86 Million | -36.04 Million | -2.34 Million | -9.69 Million | - | -557 Thousand |
| Investment purchases | - | -35.29 Million | -2.34 Million | -9.69 Million | - | -5 Million |
| Sales/Maturities of investments | - | 124.76 Million | - | - | - | - |
| Other Investing Activities | - | - | - | -17.04 Million | -10 Million | - |
| Financing Cash Flow | 311.71 Million | 181.33 Million | 174.23 Million | 78.88 Million | 325.99 Million | 53.67 Million |
| Debt repayment | -188.31 Million | -85.65 Million | -205.56 Million | -3.07 Million | -264.64 Million | -3.24 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -55 Million | - | - | - |
| Common Stock Issuance | 402.33 Million | 201.82 Million | 317.86 Million | 47.69 Million | 83.81 Million | 57.92 Million |
| Other Financing Activities | 97.69 Million | 65.16 Million | 116.93 Million | 34.26 Million | -22.46 Million | -1.01 Million |
| Accounts receivables | -5.68 Million | -2.95 Million | -1.05 Million | -10.62 Million | -1.62 Million | -515 Thousand |
| Accounts payables | 9.87 Million | -3.87 Million | -3.67 Million | 10.22 Million | 3.57 Million | 1.59 Million |
| Inventory | -9.51 Million | 8.61 Million | 10.2 Million | - | - | - |
| Other working capital | 74.87 Million | -4.57 Million | -1.67 Million | -2.97 Million | 4.04 Million | -18.67 Million |
| Cash at beginning of period | 36.66 Million | 56.46 Million | 80.76 Million | 213.33 Million | 20.42 Million | 82.39 Million |
| Cash at end of period | 23.63 Million | 36.66 Million | 56.46 Million | 80.76 Million | 168.33 Million | 20.42 Million |
| Capital Expenditure | -13.65 Million | -8.87 Million | -37.57 Million | -11.44 Million | -21.19 Million | -10.97 Million |
| Effect of forex changes on cash | -2.37 Million | 843 Thousand | 915 Thousand | -277 Thousand | -135 Thousand | 65 Thousand |
| Net cash flow / Change in cash | -13.03 Million | -19.79 Million | -24.3 Million | -132.56 Million | 147.9 Million | -61.96 Million |
| Free Cash Flow | -307.51 Million | -290.69 Million | -197.11 Million | -184.43 Million | -132.96 Million | -110.15 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -108.43 Million | -154.62 Million | -577.75 Million | -227.11 Million | -90.62 Million | -219.47 Million |
| Depreciation & Amortization | 3.59 Million | 3.62 Million | 13.24 Million | 3.35 Million | 3.35 Million | 3.23 Million |
| Deferred income taxes | -11.84 Million | 11.49 Million | -1.83 Million | -1.15 Million | -11 Thousand | -1.75 Million |
| Stock-based compensation | 15.19 Million | 18.28 Million | 74.84 Million | 17.23 Million | 18.5 Million | 18.32 Million |
| Change in working capital | 33.45 Million | 30.64 Million | 69.55 Million | 43.56 Million | 24.9 Million | 5.71 Million |
| Other non-cash items | 10.3 Million | 11.13 Million | 128.09 Million | 95.78 Million | -17.3 Million | 112.97 Million |
| Investing Cash Flow | -140 Thousand | 1.68 Million | -28.51 Million | -5.03 Million | -8.09 Million | -1.72 Million |
| Investments in PPE | -140 Thousand | -86 Thousand | -13.65 Million | -4.52 Million | -3.83 Million | -2.7 Million |
| Acquisitions | - | - | -14.86 Million | -510 Thousand | -4.25 Million | 977 Thousand |
| Investment purchases | - | - | - | 7.8 Million | -4.25 Million | 977 Thousand |
| Sales/Maturities of investments | - | 1.77 Million | - | - | - | - |
| Other Investing Activities | - | 1.77 Million | - | - | - | - |
| Financing Cash Flow | 88.81 Million | 61.19 Million | 311.71 Million | 25.08 Million | 71.49 Million | 41.77 Million |
| Debt repayment | -91.63 Million | -38.22 Million | -188.31 Million | -35.52 Million | -41.44 Million | -63.02 Million |
| Dividends payments | -11 Thousand | -14.28 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -2.18 Million | 22.97 Million | 402.33 Million | 62.29 Million | 71.45 Million | 104.14 Million |
| Other Financing Activities | -10.97 Million | 75.47 Million | 97.69 Million | -1.69 Million | 41.48 Million | 645 Thousand |
| Accounts receivables | -6.2 Million | -2.04 Million | -5.68 Million | -278 Thousand | -3.01 Million | 3.59 Million |
| Accounts payables | 6.9 Million | 18.23 Million | 9.87 Million | 4.16 Million | 4.28 Million | 3.99 Million |
| Inventory | -498 Thousand | -1.33 Million | -9.51 Million | -5.01 Million | 6.87 Million | -5.39 Million |
| Other working capital | -3.65 Million | 45 Thousand | 74.87 Million | 44.69 Million | 16.75 Million | 3.51 Million |
| Cash at beginning of period | 37.65 Million | 23.63 Million | 36.66 Million | 70.68 Million | 70.34 Million | 111.9 Million |
| Cash at end of period | 69.74 Million | 37.65 Million | 23.63 Million | 23.63 Million | 70.68 Million | 70.34 Million |
| Capital Expenditure | -140 Thousand | -86 Thousand | -13.65 Million | -4.52 Million | -3.83 Million | -2.7 Million |
| Effect of forex changes on cash | -920 Thousand | 600 Thousand | -2.37 Million | 1.24 Million | -1.89 Million | -616 Thousand |
| Net cash flow / Change in cash | 32.09 Million | 14.02 Million | -13.03 Million | -47.05 Million | 341 Thousand | -41.56 Million |
| Free Cash Flow | -55.79 Million | -49.54 Million | -307.51 Million | -72.86 Million | -65 Million | -83.69 Million |
API
BCNAY
300652
EKCS
CDMGF
301123